Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
100. Characterization of the antiparkinsonian effects of the new adenosine A 2A receptor<br />
antagonist ST1535: acute and subchronic stu<strong>di</strong>es in rats<br />
Tronci Elisabetta (1) , Simola N. (1) , Borsini F. (4) , Schintu N. (1) , Frau L. (1) , Carminati P. (4) , Morelli<br />
M. (1,2,3)<br />
(1) Department of Toxicology, (2) Centre of Excellence for Neurobiology of Dependence, (3) CNR<br />
Institute of Neuroscience, University of Cagliari, Italy, (4) Sigma-Tau Industrie Farmaceutiche<br />
Riunite S.p.A., Pomezia (Rome), Italy<br />
101. Evaluation of the neuroprotective effect of THE A 2A receptor antagonist SCH58261<br />
on the MPTP mouse model of Parkinson’s <strong>di</strong>sease<br />
Schintu Nicoletta, Carta A.R., Morelli M.<br />
Department of Toxicology, University of Cagliari, Italy<br />
102. Mitochondrial factors involved in Parkinson's <strong>di</strong>sease by MPTP toxycity in Macaca<br />
Fascicularis and drug effect<br />
Brera Francesca, Gorini A., Villa R.F.<br />
Dipartimento <strong>di</strong> Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari Sezione <strong>di</strong><br />
Farmacologia e Biotecnologie Farmacologiche Piazza Botta, 11 - 27100 Pavia, Università <strong>degli</strong><br />
<strong>Stu<strong>di</strong></strong> <strong>di</strong> Pavia<br />
103. CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity<br />
Sgadò Paola, Viaggi C., Vaglini F., Par<strong>di</strong>ni C., Caramelli A., Corsini G.U.<br />
Department of Neuroscience, Section of Pharmacology, University of Pisa and Center of<br />
Excellence ‘AMBISEN’ for the study of Environmental Toxins and CNS Diseases, Pisa, Italy<br />
104. Behavioural characterization of engrailed mutant mice as model of Parkinson’s<br />
<strong>di</strong>sease<br />
Pontis Silvia 1 , Pinna A. 2 , Sgadò P. 3 , Corsini G.U. 3 , Morelli M. 1,2<br />
1 Department of Toxicology, University of Cagliari, Italy. 2 CNR Institute for Neuroscience,<br />
Cagliari, Italy. 3 Department of Neuroscience, Pisa, Italy<br />
89<br />
105. Low and high dyskinetic treatments induce <strong>di</strong>fferent motor responses and mRNA<br />
changes in Caudate-Putamen in the 6-OHDA rat model of Parkinson’ s <strong>di</strong>sease<br />
Frau Lucia 1 , Carta A. R. 1 , Pinna A. 2 , Pontis S. 1 , Morelli M. 1,2 .<br />
1 Department of Toxicology, University of Cagliari. 2 CNR, Institute of Neuroscience, Cagliari<br />
106. Blockade of pallidal adenosine A 2A receptors potentiates contralateral rotational<br />
behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats<br />
Simola Nicola a , Fenu S. a , Baral<strong>di</strong> P.G. b , Tabrizi M. A. b , Morelli M. a<br />
a Department of Toxicology and Centre of Excellence for Neurobiology of Dependence,<br />
University of Cagliari, Cagliari, Italy; b Department of Pharmaceutical Sciences, University of<br />
Ferrara, Ferrara, Italy<br />
107. Analysys of the MPP + uptake in mesencephalic cell cultures from CYP 2E1 Knock-out<br />
mice<br />
Caramelli Andrea, Par<strong>di</strong>ni C., Viaggi C., Vaglini F., Sgadò P., Corsini G.U.<br />
Dip. <strong>di</strong> Neuroscienze Sez. Farmacol. Università <strong>di</strong> Pisa<br />
108. Effects of <strong>di</strong>rect and in<strong>di</strong>rect cannabinoid receptor agonists on levodopa-induced<br />
dyskinesias ina rat model of Parkinson's <strong>di</strong>sease<br />
Morgese Maria Grazia 1,3 , Cassano T. 1 , Trabace L. 1 , Cuomo V. 2 , Giuffrida A. 3<br />
1 Department of Biome<strong>di</strong>cal Sciences, University of Foggia, Italy;<br />
2 Department of<br />
Pharmacology and General Physiology, University of Rome, ‘La Sapienza’, Italy; 3 Department<br />
of Pharmacology, University of Texas Health Science Center at San Antonio, Texas, U.S.A<br />
pag_dx.indd 1 30/05/2007 4.09.03